AM ResearchMedical AMRegenerative MedicineResearch & Education

3D printing to enable new osteoporosis treatment

Thanks to a collaborative effort between scientists from Tomsk State University (TSU) and Sharif University of Technology

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

According to the World Health Organization, osteoporosis, which significantly increases the risk of bone fracture, is one of the most common non-communicable diseases – ranking fourth after cardiovascular disease, diabetes mellitus, and cancer. Scientists from Tomsk State University (TSU) and Sharif University of Technology, in Tehran, Iran, are developing a new treatment for osteoporosis that will effectively restore bone tissue. The research is supported by the international Russian Science Foundation grant.

“Conventional treatment approaches to osteoporosis are drugs and hormone therapy,” said Irina Kurzina, the project leader and head of the Department of Natural Compounds, Pharmaceutical, and Medical Chemistry of the Faculty of Chemistry at Tomsk State University. “We are developing a new means of restoring osteoporotic bone defects. Biodegradable 3D printed polymeric scaffolds will deliver it to the problem area.”

TSU will develop super macromolecules – active substances that treat osteoporosis and restore the structure and density of bone tissue – while Sharif University of Technology will develop 3D printed polymeric scaffolds.

“Medical materials science is a well-developed field at Sharif University of Technology. Its scientists have extensive experience in applying 3D printing technologies for ceramic and polymer-based composite materials,” said Irina Kurzina. “The main feature of the scaffolds that our Iranian colleagues are developing is that the carrier will gradually decompose in the body, and active substances will be released from its matrix that will stop the process of bone degradation and start restoration processes.”

The project will span three years, and the researchers will conduct initial testing on cell cultures at the final stage. If the parties agree to extend the project, the researchers will conduct in-vitro and in-vivo studies, which are necessary to introduce the new product into clinical practice.

Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Edward Wakefield

Edward is a freelance writer and additive manufacturing enthusiast looking to make AM more accessible and understandable.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services


Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.